MAPT and Alzheimer disease: Another miRNA of the cluster predicting conversion of early MCI to AD, miR-26b.5p, acts via cyclin-dependent kinase 5 upregulation, tau phosphorylation, aberrant cell cycle entry, and neuronal death [129], although its role has been discussed in cancer as well as in cerebral ischemia-reperfusion injuries [130,131].